Published in Curr Microbiol on April 24, 2007
Biofilm Formation As a Response to Ecological Competition. PLoS Biol (2015) 2.42
Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis. Eur J Clin Microbiol Infect Dis (2009) 1.00
The effect of environmental conditions on biofilm formation of Burkholderia pseudomallei clinical isolates. PLoS One (2012) 0.98
Response of Burkholderia cenocepacia H111 to micro-oxia. PLoS One (2013) 0.92
Characterization of the poly-β-1,6-N-acetylglucosamine polysaccharide component of Burkholderia biofilms. Appl Environ Microbiol (2011) 0.91
A metaproteomics approach to elucidate host and pathogen protein expression during catheter-associated urinary tract infections (CAUTIs). Mol Cell Proteomics (2015) 0.79
Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients. Clin Microbiol Rev (2014) 0.79
Burkholderia pseudomallei Biofilm Promotes Adhesion, Internalization and Stimulates Proinflammatory Cytokines in Human Epithelial A549 Cells. PLoS One (2016) 0.76
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet (1993) 7.12
The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol (2005) 5.38
Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet (1990) 4.39
Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol (2001) 4.02
Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ Microbiol (2003) 4.01
The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med (1995) 3.36
Bacterial contingency loci: the role of simple sequence DNA repeats in bacterial adaptation. Annu Rev Genet (2006) 2.86
Microtiter plate assay for assessment of Listeria monocytogenes biofilm formation. Appl Environ Microbiol (2002) 2.82
Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol (1997) 2.72
Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis (1998) 2.43
Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun (1996) 1.82
Invasion and intracellular survival of Burkholderia cepacia. Infect Immun (2000) 1.74
Update on the Burkholderia cepacia complex. Curr Opin Pulm Med (2005) 1.62
An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis (1999) 1.59
Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology (1999) 1.51
Burkholderia cepacia complex species: health hazards and biotechnological potential. Trends Microbiol (2006) 1.49
Burkholderia cepacia genomovar III Is a common plant-associated bacterium. Appl Environ Microbiol (2001) 1.39
Virulence factors of Burkholderia cepacia. FEMS Immunol Med Microbiol (1994) 1.39
Intracellular survival of Burkholderia cenocepacia in macrophages is associated with a delay in the maturation of bacteria-containing vacuoles. Cell Microbiol (2006) 1.35
Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J Clin Microbiol (2004) 1.33
The mgtC gene of Burkholderia cenocepacia is required for growth under magnesium limitation conditions and intracellular survival in macrophages. Infect Immun (2006) 1.22
Patterns of epithelial cell invasion by different species of the Burkholderia cepacia complex in well-differentiated human airway epithelia. Infect Immun (2002) 1.21
Pathogen evolution in vivo: genome dynamics of two isolates obtained 9 years apart from a duodenal ulcer patient infected with a single Helicobacter pylori strain. J Clin Microbiol (2005) 1.20
Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells. Infect Immun (2000) 1.20
Modulation of biofilms of Pseudomonas aeruginosa by quinolones. Antimicrob Agents Chemother (1995) 1.16
Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy. J Clin Microbiol (2005) 1.02
Evaluation of three oligonucleotide primer sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli. J Clin Pathol (1999) 1.00
Invasion of human type II pneumocytes by Burkholderia cepacia. Microb Pathog (2001) 0.99
Burkholderia respiratory tract infections in Italian patients with cystic fibrosis: molecular characterization. J Infect (2006) 0.98
Update on cystic fibrosis epidemiology. Curr Opin Pulm Med (2004) 0.88
Differential invasion of respiratory epithelial cells by members of the Burkholderia cepacia complex. Clin Microbiol Infect (2002) 0.83
[Quorum-sensing regulation of gene expression: fundamental and applied aspects and the role in bacterial communication]. Mikrobiologiia (2006) 0.81
Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients. APMIS (2008) 1.11
Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma. Blood (2005) 1.09
Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin. Exp Dermatol (2007) 0.93
Novel approaches for the design and discovery of quorum-sensing inhibitors. Expert Opin Drug Discov (2014) 0.87
Dual regulation of osteopontin production by TLR stimulation in dendritic cells. J Leukoc Biol (2013) 0.80
Survey of phenotypic and genetic features of streptococcus pyogenes strains isolated in Northwest Italy. Curr Microbiol (2005) 0.79